Sign in Sign up for free

Interpace Biosciences Inc Operating margin

What is the Operating margin of Interpace Biosciences Inc?

The Operating margin of Interpace Biosciences Inc is 4.27%

What is the definition of Operating margin?



Operating margin is the ratio of operating income divided by net sales and presented in percent.

ttm (trailing twelve months)

Operating margin is an indicator of profitability and is often used to compare the profitability of companies and industries of differing sizes. Companies are collections of projects and markets, individual areas can be judged on how successful they are at adding to the corporate net profit. Not all projects are of equal size, however, and one way to adjust for size is to divide the profit by sales revenue. The resulting ratio is the percentage of sales revenue that gets 'returned' to the company as net profits after all the related costs of the activity are deducted.

Operating margin of companies in the Health Care sector on NASDAQ compared to Interpace Biosciences Inc

What does Interpace Biosciences Inc do?

advancing patient care through molecular diagnostic testing. interpace diagnostics develops molecular diagnostic tests. our molecular diagnostic tests provide unparalleled accuracy and clarity to improve outcomes in patients facing a cancer diagnosis. you can be assured that all of the molecular tests we offer are driven by rigorous, validated science. we power the future of molecular diagnostics, delivering cutting-edge and much-needed mutational analysis that helps risk-stratify for thyroid, pancreatic, and other cancers to better inform treatment decisions. the unique molecular diagnostic tests we offer enable healthcare providers to avoid unnecessary surgeries and better assess the risk of cancer progression in their patients.

Companies with operating margin similar to Interpace Biosciences Inc